首页> 外文期刊>亚太热带医药杂志(英文版) >Recognition of a multiple antigen peptide containing sequence from mimotope of the dengue type 3 virus NS4B protein by human antibodies
【24h】

Recognition of a multiple antigen peptide containing sequence from mimotope of the dengue type 3 virus NS4B protein by human antibodies

机译:人类抗体识别登革3型病毒NS4B蛋白模拟表位的多抗原肽序列

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: To evaluate the recognition of NS4B mimotope, as multiple antigen peptide (MAP), by dengue antibodies presents in serum samples from patients with different serotype infections. Methods: A MAP containing mimotope sequence was synthesized and used to evaluate the recognition of NS4B mimotope as MAP by a panel of 66 human sera from dengue cases by an indirect ELISA assay. Results: The MAP differentiated between sera from dengue viruses infected patients and sera from healthy individuals and the best reactivity was shown by serum from dengue type 3 virus patients. The recognition was more intense with serum from patients with secondary infection. Conclusions: The findings suggest the potential use of NS4B mimotope on the development of a multi-epitope diagnostic tool. These results are important for further immunogenicity studies.
机译:目的:评估不同血清型感染患者血清样品中登革热抗体对NS4B模拟表位作为多抗原肽(MAP)的识别作用。方法:合成了一个包含拟表位序列的MAP,并通过间接ELISA分析法评估了一组来自登革热病例的66个人血清中NS4B拟表位作为MAP的识别。结果:MAP区分了感染登革热病毒患者的血清和健康个体的血清,而登革热3型病毒患者的血清显示出最佳反应性。继发感染患者的血清对识别的认识更强。结论:研究结果表明NS4B模拟表位在开发多表位诊断工具中的潜在用途。这些结果对于进一步的免疫原性研究很重要。

著录项

  • 来源
    《亚太热带医药杂志(英文版)》 |2016年第2期|126-129|共4页
  • 作者单位

    Implementation and Design of Clinical trials, Clinical Research and Impact Evaluation Direction, Finlay Institute, 11600 Havana, Cuba;

    'Pedro Kourí' Tropical Medicine Institute (IPK), PAHO/WHO Collaborating Center for the Study of Dengue and its Vector, 17100 Havana, Cuba;

    Implementation and Design of Clinical trials, Clinical Research and Impact Evaluation Direction, Finlay Institute, 11600 Havana, Cuba;

    'Pedro Kourí' Tropical Medicine Institute (IPK), PAHO/WHO Collaborating Center for the Study of Dengue and its Vector, 17100 Havana, Cuba;

    'Pedro Kourí' Tropical Medicine Institute (IPK), PAHO/WHO Collaborating Center for the Study of Dengue and its Vector, 17100 Havana, Cuba;

    Implementation and Design of Clinical trials, Clinical Research and Impact Evaluation Direction, Finlay Institute, 11600 Havana, Cuba;

    'Pedro Kourí' Tropical Medicine Institute (IPK), PAHO/WHO Collaborating Center for the Study of Dengue and its Vector, 17100 Havana, Cuba;

    Implementation and Design of Clinical trials, Clinical Research and Impact Evaluation Direction, Finlay Institute, 11600 Havana, Cuba;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号